Scroll To Top
Search by Speciality

6TH INTERNATIONAL HIV PERSISTENCE WORKSHOP

JW Marriott Marquis Miami * | Miami, USA
From 1700 to 1700 USD
Event Preview
EXPIRED
This event
is Finished
Title: 6TH INTERNATIONAL HIV PERSISTENCE WORKSHOP
Specialty: , Internal Medicine
Dates: From Dec, 3, 2013 to Dec, 6, 2013
Location: Miami, USA
Type: Workshop
Registration Cost: From 1700 to 1700 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Dec
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for MIAMI, Usa.
General Info
Event Venue:

JW Marriott Marquis Miami *

MIAMI, USA Visit the Venue to read more
Currency:
USD
Event Overview
Welcome message:

I am delighted to announce the Sixth International Workshop on HIV Persistence during Therapy, scheduled for December 3-6, 2013 at the JW Marriott Marquis Hotel Miami.

Since the first edition of this workshop in 2003 in St Maarten, the issue of “HIV Persistence & Reservoirs” has become more relevant, not only for the biologist but also for the clinician facing the problem of the long-term control of this persistent retroviral infection. 

Several meetings have now included reviews on these topics in their program, but this workshop is unanimously recognized as “The Reference Workshop on HIV Reservoirs & Eradication Strategies.” Our main objective is to keep it driven by Science and new data.

The program format will continue to follow the past successes and include presentations of new, unpublished data and a panel of experts to sum up the current advances in the field. The number of participants is now limited to 250. As in the past, abstract selection will be extremely rigorous and conducted by the Scientific Committee, focusing on new progress in the field. 

I hope to see you in December in Miami! 





Alain Lafeuillade, MD, Chair

Registration Not yet available Register Now
Accommodation
Accommodation:
The entire Workshop will be held at the following hotel:

JW Marriott Marquis Hotel Miami
Miami, Florida USA


 

APPLICATION INFORMATION
The Sixth International Workshop on HIV Persistence during Therapy is a closed workshop with a limited attendance of 250 delegates. All individuals interested in attending this Workshop MUST submit an application/abstract prior to the deadline of Friday, September 6, 2013. 

Potential participants involved in the field, but not submitting an abstract this year, should also submit an online application before September 6th, which will be studied by the Steering Committee. Individuals not conducting bench research, but who are involved in the HIV/AIDS field at a policy level, are also encouraged to apply.

Online application/abstract submission is available on this Workshop website. Priority is given to those individuals submitting abstracts. All applications will be acknowledged, but this acknowledgment does NOT represent a confirmation of acceptance to register. Applications sent via E-mail cannot be accepted.

Back to top

SESSION TOPICS

  • In vivo and in vitro models of HIV persistence
  • Basic science of HIV latency
  • Assays to measure HIV persistence
  • Clinical virology of HIV persistence
  • Anatomic and non-CD4 cell reservoirs
  • Immunology of HIV persistence
  • Pharmacology of HIV persistence
  • Drug discovery
  • Practical issues in designing cure trials
  • New therapeutic approaches targeting the reservoir

Back to top

REGISTRATION FEE INFORMATION

Registration Fees (Payable in US dollars)

    • Workshop registration fee: $1700
      *this TENTATIVE registration fee is subject to change as corporate sponsorship increases.
Hotel accommodations:   $910
Registration fee (inclusive of meeting materials and meals): $790
  • Accompanying guests, sharing room with delegate: $600

Upon notification of acceptance, the delegate must REGISTER for the Workshop. Payment of the Workshop registration fee includes the following:

  • Entrance into all scientific sessions, including poster area
  • Single-occupancy accommodation for three (3) nights
  • Official Workshop materials
  • Breakfast, lunch, refreshment breaks and dinner during the days of the conference

Payment of the Accompanying Guest registration fee includes the following:

  • Breakfast, lunch, refreshment breaks and dinner during the days of the conference

Back to top

DISCLOSURE
It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials. 

WORKSHOP OBJECTIVES
Advancement in the following categories:

  • Models of HIV Persistence
  • Basic Science
  • Virological Aspects
  • Immunological Aspects
  • Acute HIV Infection
  • Anatomic Reservoirs
  • Drug Discovery
  • New Therapeutic Approaches

STATEMENT OF NEED
The content of the Sixth International Workshop on HIV Persistence during Therapy was determined by assessment of educational need, including feedback from prior programs and new medical knowledge.

TARGET AUDIENCE
This Workshop was designed to interest physicians, clinicians, scientists and clinical researchers in the HIV persistence and latency arena.

CONTINUING EDUCATION CREDIT
This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and Alain Lafeuillade at General Hospital. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Back to top

SCHOLARSHIP FUND
Depending on funding availability, a limited number of scholarships may be available for young scientists, age limit of 35 for eligibility. Please visit the workshop website for more information

Further Details:

Due to nature of this closed Workshop and the proximity of registration to the commencement of the Workshop itself, all registration fees are nonrefundable.

Contact

For all inquiries relating to the Workshop, please contact:



Telephone: +1 770 573 3020
Facsimile: +1 866 534 643
E-mail: kmorris@informedhorizons.com
Website: www.informedhorizons.com

Scientific Content Up to Date
Submission Info

he Steering Committee requires that presenting authors submit their abstracts electronically via this website. Abstract submissions will only be accepted from the presenting author. All correspondence regarding the status of the abstract will be sent only to the presenting author. Co-authors of abstracts submitted to the Workshop must ALSO complete an application to be considered for admittance.

The abstract/application process is combined into one online step. During this online process, if you indicate on the application form that you are the presenting author and intend to submit an abstract, you will be forwarded to the ABSTRACT SUBMISSION page, providing an opportunity to upload the abstract. There is no need to complete the application/abstract form until your abstract is ready for submission.

To submit an abstract click on the SUBMIT ABSTRACT button at the bottom of the page and follow the step-by-step directions, which will enable you to provide the presenting author contact information, answer a few questions, and then upload the file containing your abstract from the computer system that you are using to access this website. To ensure your abstract retains any special characters or formatting the abstract must be in MICROSOFT WORD format. 

Editorial Guidelines for Presented Content:

Format 
The publisher of the abstract book does not allow figures or tables to appear in the submitted abstract.

  • All abstracts should be sent as Microsoft Word files.
  • All abstracts should be typed in English using single-line spacing.
  • All abstracts should be typed in Arial font at a size of 11 points.
  • Abstracts must not exceed 350 words.

Author names and affiliations should be written as follows, with the presenting author's name underlined: 
AN Author1, AN Author2 and AN Author3

1 University of London, London, UK; 2 University of Frankfurt, Frankfurt, Germany; and 3 University of Paris, Paris, France.

The body of the uploaded abstract submission should not exceed 350 words; this limit excludes the title, authors and affiliations.

  • Results and conclusions must be included; it is not acceptable to state that results will be presented.
  • Abstract text may be divided into the following sections: objectives/aim, methods, results, conclusion(s)/discussion.
  • Tables, graphs and references must NOT be used.
  • Acknowledgements may be listed after the abstract.
  • Generic (not trade) names for drugs should be used and written in full (not denoted by initials).
  • Dosing regimens should be written in full. For example, "TID" should be written as "three times daily."

Clearly define all concepts and abbreviations at first use. If English is not your primary language, attempt to have your abstract reviewed by a native English speaker. To be acceptable, abstracts shall contain a concise statement of the research. It is recommended that the author follow the structured format below:

Title (not included in 350 word limit)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles). 

Authors/Affiliations (not included in 350 word limit)
Authors' names should be entered using initial(s) for the first and middle names followed by the full last name, with presenting author underlined (e.g. AN Author1, AN Author2 and AN Author3). 

All author affiliations should be entered as follows:
1 University of London, London, UK; 2 University of Frankfurt, Frankfurt, Germany; and 3 University of Paris, Paris, France. 

Background
State the problem under investigation or a hypothesis. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed. 

Methods
Explain the experimental methods used. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

Results
List the essential results obtained in summary form, with enough quantitative data to permit evaluation by reviewers. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

Conclusion 
Summarize the findings. It is unacceptable to use statements such as "the results will be discussed". For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed. 

In addition to the uploaded abstract, the following additional information will be collected on the abstract submission form: 

Contact Information 
The presenting author must enter a complete address to ensure that correspondence arrives promptly and easily. 

Abstract Title (should be the same as in the uploaded abstract)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles).

Sample Abstract
To view a sample abstract, click here. 

The sample form is an Adobe Acrobat document. If your computer cannot read the sample, please click here to download Adobe's free Acrobat Reader. 

Sponsors Exhibitors
Contact
Organising Agency

Contact: Kristen Morris , Informed Horizons, LLC

Phone: 770-573-3020

Fax: 866-534-6438

Event map
Revelant Events